Other
Misoprostol
0
Pipeline Programs↗
3
Active Trials↗
1
Companies Involved↗
Misoprostol is an early-stage landscape with 0 programs across 1 company. The most active players are Ferring.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
89
clinical trials
Completed63 · 71%
Unknown status16 · 18%
Terminated4 · 4%
Withdrawn3 · 3%
Recruiting2 · 2%
Not yet recruiting1 · 1%
Clinical Trials
Trial Activity
89 trials
Misoprostol Versus Oxytocin Infusion On Reducing Blood Loss During Abdominal Myomectomy
Recruiting·—·Phase 3·NCT06325501·56 enrolled
Use of Misoprostol in Case of Insertion Failure of Intrauterine Contraceptives
Completed·—·Phase 4·NCT01754649·102 enrolled
Misoprostol Prior to Intrauterine Contraceptive Device Insertion
Completed·—·Phase 1·NCT02412033·140 enrolled
Rectal Misoprostol as a Hemostatic Agent During Abdominal Myomectomy
Completed·TThe University of Texas Health Science Center at San Antonio·Phase 4·NCT03064568·18 enrolled
Combined Vaginal Misoprostol and Perivascular Vasopressin
Completed·—·Phase 4·NCT03815344·74 enrolled
Page 1 of 6
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)